Literature DB >> 23165229

Motion in radiotherapy: photon therapy.

Stine S Korreman1.   

Abstract

This review considers the management of motion in photon radiation therapy. An overview is given of magnitudes and variability of motion of various structures and organs, and how the motion affects images by producing artifacts and blurring. Imaging of motion is described, including 4DCT and 4DPET. Techniques for monitoring motion in real time by use of surrogates are reviewed. Treatment planning for various motion-management treatment delivery strategies is discussed, including choice of planning image, treatment field margins and dose calculation. Imaging techniques displaying motion in the treatment room for pre-treatment as well as real-time imaging for localization and verification are covered, and their use for various motion-management treatment delivery techniques is discussed. Use of motion management for different treatment sites—breast, lung and other sites—is elaborated, and gating, breath-hold and beam tracking strategies are described. Suggestions are given for breast and lung for practicable protocols for routine clinical use of motion management, including decision strategies. Finally, a perspective of the future of motion management in photon radiation therapy is given.

Entities:  

Mesh:

Year:  2012        PMID: 23165229     DOI: 10.1088/0031-9155/57/23/R161

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  35 in total

1.  Optimization of an on-board imaging system for extremely rapid radiation therapy.

Authors:  Erica M Cherry Kemmerling; Meng Wu; He Yang; Peter G Maxim; Billy W Loo; Rebecca Fahrig
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

2.  Intensity modulated proton therapy.

Authors:  H M Kooy; C Grassberger
Journal:  Br J Radiol       Date:  2015-05-27       Impact factor: 3.039

3.  The potential of positron emission tomography for intratreatment dynamic lung tumor tracking: a phantom study.

Authors:  Jaewon Yang; Tokihiro Yamamoto; Samuel R Mazin; Edward E Graves; Paul J Keall
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

4.  Under-reported dosimetry errors due to interplay effects during VMAT dose delivery in extreme hypofractionated stereotactic radiotherapy.

Authors:  Tobias Gauer; Thilo Sothmann; Oliver Blanck; Cordula Petersen; René Werner
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

5.  An offline technique to evaluate residual motion of the diaphragm during deep inspiratory breath-hold from cone-beam CT datasets.

Authors:  Manuel Blessing; Julian Hofmann; Lena Vogel; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Florian Stieler; Anna Simeonova-Chergou
Journal:  Strahlenther Onkol       Date:  2018-05-22       Impact factor: 3.621

6.  Rapid estimation of 4DCT motion-artifact severity based on 1D breathing-surrogate periodicity.

Authors:  Guang Li; Marshall Caraveo; Jie Wei; Andreas Rimner; Abraham J Wu; Karyn A Goodman; Ellen Yorke
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

Review 7.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

8.  Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Antoi P W Meeuwis; Charlotte S van der Vos; Martin Gotthardt; Wim J G Oyen; Eric P Visser
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

9.  Couch and multileaf collimator tracking: A clinical feasibility study for pancreas and liver treatment.

Authors:  Lei Zhang; Thomas LoSasso; Pengpeng Zhang; Margie Hunt; Gig Mageras; Grace Tang
Journal:  Med Phys       Date:  2020-09-11       Impact factor: 4.071

Review 10.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.